Most cited papers from Piramal (United States)

Piramal (United States)

What are the most cited papers from Piramal (United States)?

The most cited paper from Piramal (United States) is "β-Amyloid accumulation in the human brain after one night of sleep deprivation" (Ehsan Shokri Kojori, Gene‐Jack Wang, Corinde E. Wiers et al., 2018), with 902 citations. Next come "18F-Florbetaben PET beta-amyloid binding expressed in Centiloids" (185) and "Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development" (160).

Published TypeFieldAccessCitations

Showing 35 of 35 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	β-Amyloid accumulation in the human brain after one night of sleep deprivation Ehsan Shokri Kojori, Gene‐Jack Wang, Corinde E. Wiers et al. · Proceedings of the National Academy of Sciences Open access	9 Apr 2018	902
2	18F-Florbetaben PET beta-amyloid binding expressed in Centiloids Christopher Cleon Rowe, Vincent Doré, Gareth R. Jones et al. · European Journal of Nuclear Medicine and Molecular Imaging Open access	22 Jun 2017	185
3	Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development Gil D. Rabinovici, María C. Carrillo, Mark S. Forman et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions Open access	20 Sep 2016	160
4	Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment Santiago Bullich, John Peter Seibyl, Ana María Catafau et al. · NeuroImage Clinical Open access	2017	131
5	The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data Mark E. Schmidt, Ping Chiao, Gregory Klein et al. · Alzheimer s & Dementia Open access	24 Nov 2014	126
6	Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools? Peter Jeffrey Snyder, Kristin Kahle‐Wrobleski, Stephen K. Brannan et al. · Alzheimer s & Dementia	Nov 2014	101
7	The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics Prachi Gupta, Brendan L. Thompson, Banrida Wahlang et al. · Drug Delivery and Translational Research Open access	3 Oct 2017	69
8	Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET Santiago Bullich, Victor L. Villemagne, Ana María Catafau et al. · Journal of Nuclear Medicine Open access	9 Feb 2017	69
9	Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual–Time-Window Acquisition Protocol Santiago Bullich, Henryk Barthel, Norman Koglin et al. · Journal of Nuclear Medicine Open access	24 Nov 2017	45
10	Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB) Enchi Liu, Johan Luthman, Jesse M. Cedarbaum et al. · Alzheimer s & Dementia	Jul 2015	12
11	Synthesis and Photothermal Effects of Intracellular Aggregating Nanodrugs Targeting Nasopharyngeal Carcinoma Ying Zhong, Naveen Kumar Bejjanki, Xiangwan Miao et al. · Frontiers in Bioengineering and Biotechnology Open access	16 Sep 2021	11
12	Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging Rafid Mustafa, Jared R. Brosch, Gil D. Rabinovici et al. · Alzheimer Disease & Associated Disorders Open access	14 Nov 2017	8
13	Advances in Aβ Plaque Detection and the Value of Knowing: Overcoming Challenges to Improving Patient Outcomes in Alzheimer’s Disease Aleksandar Jovalekic, Santiago Bullich, Ana María Catafau et al. · Neurodegenerative Disease Management	4 Nov 2016	4
14	Ross C. Terrell, PhD, an Anesthetic Pioneer William Burns Burns, Edmond I. Eger · Anesthesia & Analgesia	4 Jun 2011	4
15	Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone Min S. Lee, Deborah I. Bunin, Anna M. Furimsky et al. · Biology of Reproduction Open access	5 Sep 2023	3
16	Building and Leading Successful Cross-Functional Teams Manoj Zalpuri, Amy M. Hamlin · ACS symposium series Conference paper	2020	2
17	IC‐P‐003: Optimal Reference Region to Measure Longitudinal Amyloid‐Beta Change with 18F‐Florbetaben PET Santiago Bullich, Ana María Catafau, Victor L. Villemagne et al. · Alzheimer s & Dementia	Jul 2016	2
18	Brain Atrophy in Early and Late Onset Alzheimer’s Disease and Suspected Non-Alzheimer’s Pathophysiology (P4.098) Eddie Stage, Meredith Lois Phillips, Tuğçe Duran et al. · Neurology	18 Apr 2017	1
19	[IC‐P‐162]: COMPARISON OF 18F‐FLORBETABEN QUANTIFICATION RESULTS USING MR‐BASED AND MR‐LESS CAPAIBL: VALIDATION AGAINST HISTOPATHOLOGY Vincent Doré, Santiago Bullich, Christopher Cleon Rowe et al. · Alzheimer s & Dementia	Jul 2017	1
20	Patient and caregiver assessment of perceived benefits from clinical use of amyloid PET imaging (P6.108) Rafid Mustafa, Gil D. Rabinovici, Bradford Clark Dickerson et al. · Neurology	18 Apr 2017	0
21	Mining Data from Verbal Fluency Word Lists for Prediction of Amyloid Status (P4.086) David Glenn Clark, John Del Gaizo, Naira Goukasian et al. · Neurology	18 Apr 2017	0
22	[P4–269]: COMPARISON OF 18F‐FLORBETABEN QUANTIFICATION RESULTS USING MR‐BASED AND MR‐LESS CAPAIBL: VALIDATION AGAINST HISTOPATHOLOGY Vincent Doré, Santiago Bullich, Christopher Cleon Rowe et al. · Alzheimer s & Dementia	Jul 2017	0
23	[IC‐P‐216]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE‐ONSET AMYLOID‐NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS Eddie Stage, Meredith Lois Phillips, Victor Hugo Canela et al. · Alzheimer s & Dementia Open access	Jul 2017	0
24	P4‐164: 18F‐Florbetaben Suvr Cutoff Quantification Across Reference Regions and Standards of Truth and Comparison to Visual Assessment Susan De Santi, Ana María Catafau, John Peter Seibyl et al. · Alzheimer s & Dementia	Jul 2016	0
25	P2‐271: Optimal Reference Region to Measure Longitudinal Amyloid‐Beta Change with 18F‐Florbetaben Pet Santiago Bullich, Ana María Catafau, Victor L. Villemagne et al. · Alzheimer s & Dementia	Jul 2016	0
26	[P4–386]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY‐ VERSUS LATE‐ONSET AMYLOID‐NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS Eddie Stage, Meredith Lois Phillips, Victor Hugo Canela et al. · Alzheimer s & Dementia	Jul 2017	0
27	[IC‐P‐105]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY‐ VERSUS LATE‐ONSET AMYLOID‐POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS Eddie Stage, Meredith Lois Phillips, Victor Hugo Canela et al. · Alzheimer s & Dementia	Jul 2017	0
28	P3‐378: EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F‐18] FLORBETABEN Ranjan Duara, David Loewenstein, Gabriel Lizarraga et al. · Alzheimer s & Dementia	Jul 2018	0
29	Data-driven cluster analysis of neuropsychological data identifies several cognitive subtypes in early onset cognitive impairment (P6.109) Liana G. Apostolova, Kathleen A. Lane, Gil D. Rabinovici et al. · Neurology	18 Apr 2017	0
30	[P2–356]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE‐ONSET AMYLOID‐POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS Eddie Stage, Meredith Lois Phillips, Victor Hugo Canela et al. · Alzheimer s & Dementia Open access	Jul 2017	0
31	[P4–327]: PATIENT AND CAREGIVER ASSESSMENT OF THE BENEFITS FROM THE CLINICAL USE OF AMYLOID‐PET IMAGING Rafid Mustafa, Jared R. Brosch, Gil D. Rabinovici et al. · Alzheimer s & Dementia Open access	Jul 2017	0
32	Development of Therapeutic Area-Specific Data Standards for Brain Diseases (S9.007) Jon Neville et al. · Neurology	6 Apr 2015	0
33	IC‐P‐001: 18F‐Florbetaben Suvr Cutoff Quantification Across Reference Regions and Standards of Truth and Comparison to Visual Assessment Susan De Santi, Ana María Catafau, John Peter Seibyl et al. · Alzheimer s & Dementia Open access	Jul 2016	0
34	P4‐178: A study of optimal SUVR cutpoints and reference regions for florbetaben PET Gregory Klein, Mehul P. Sampat, Davis Staewen et al. · Alzheimer s & Dementia	Jul 2015	0
35	Budget Impact Analysis Of Using Amyloid Positron Emission Tomography (Pet) In The Diagnosis Of Alzheimer’s Disease (Ad) In The United States Luis Hernández, Songtao Guo, Sára Sándor · Value in Health Open access	May 2014	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.